文献速递角膜与眼表疾病眼整形与眼眶

IL-10基因修饰脂肪间充质干细胞通过miR-142-5p/RC3H1轴抑制滤泡辅助性T细胞应答增强对兔自身免疫性泪腺炎的治疗效果

Enhanced Therapeutic Effect of IL-10-ADSCs on Rabbit Autoimmune Dacryoadenitis By Suppressing T Follicular Helper Cell Responses Via miR-142-5p/RC3H1 Axis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

该研究构建了过表达白细胞介素10(IL-10)的兔脂肪间充质干细胞(IL-10-ADSCs),在兔自身免疫性泪腺炎模型中评估其预防和治疗效果。结果显示,静脉注射IL-10-ADSCs较未修饰ADSCs显著改善临床和病理表现,并抑制滤泡辅助性T(Tfh)细胞应答,部分通过miR-142-5p/RC3H1轴介导;发病后结膜下注射IL-10-ADSCs也能有效减轻疾病严重程度。

要点

  • IL-10-ADSCs保留ADSCs的细胞表面表型和多向分化潜能。
  • 静脉注射IL-10-ADSCs较ADSCs显著改善兔自身免疫性泪腺炎的临床和病理表现。
  • IL-10-ADSCs在体内外显著抑制Tfh细胞应答,部分通过miR-142-5p/RC3H1轴介导。

核心结论

  • IL-10-ADSCs通过抑制miR-142-5p/RC3H1轴抑制Tfh细胞应答,从而改善自身免疫性泪腺炎。
  • IL-10-ADSCs增强的治疗效果可能对提高干细胞治疗自身免疫性干眼的有效性具有重要价值。

研究设计与样本

  • 从兔脂肪组织分离ADSCs,用过表达IL-10的慢病毒转导构建IL-10-ADSCs。
  • 在兔自身免疫性泪腺炎模型上评估IL-10-ADSCs的预防和治疗效果。
  • 采用流式细胞术和Western blot评估IL-10-ADSCs对Tfh细胞的免疫调节作用。
  • 通过生物信息学分析和功能获得与缺失实验确定IL-10-ADSCs影响Tfh应答的分子机制。

主要发现

  • IL-10-ADSCs维持MSCs的细胞表面表型和多向分化潜能。
  • 静脉注射IL-10-ADSCs显著减轻自身免疫性泪腺炎,临床和病理改善显著优于ADSCs。
  • IL-10-ADSCs在体内和体外均显著抑制Tfh细胞应答,有助于减轻炎症和改善组织损伤。
  • IL-10-ADSCs对Tfh细胞的抑制功能部分通过miR-142-5p/RC3H1轴发挥。
  • 发病后结膜下注射IL-10-ADSCs有效改善自身免疫性泪腺炎的严重程度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Mesenchymal stem cells (MSCs) represent a promising therapeutic strategy in clinical research for dry eye, and their immunomodulatory effects can be enhanced through genetic modification. In this study, we constructed interleukin-10 (IL-10) gene-modified adipose-derived MSCs (IL-10-ADSCs) and investigated their protective effects and underlying mechanisms on rabbit autoimmune dacryoadenitis, an animal model of autoimmune dry eye. METHODS: ADSCs were isolated from rabbit adipose tissue and transduced with IL-10 overexpressing lentivirus. Then the preventive and therapeutic effects of IL-10-ADSCs on rabbit autoimmune dacryoadenitis were evaluated. Flow cytometry and Western blot were performed to assess the immunomodulatory effects of IL-10-ADSCs on T follicular helper (Tfh) cells. Bioinformatic analyses and functional gain and loss assays were used to determine the molecular mechanism underlying the effects of IL-10-ADSCs on Tfh responses. RESULTS: We demonstrated that IL-10-ADSCs maintain the cell surface phenotype and multi-differentiation potentials of MSCs. Intravenous injection of IL-10-ADSCs markedly attenuated autoimmune dacryoadenitis, yielding significantly superior clinical and pathological improvements compared to ADSCs. Further investigation revealed that IL-10-ADSCs administration significantly suppressed Tfh cell responses in vivo and in vitro, contributing to reduced inflammation and improved tissue damage. Mechanistically, IL-10-ADSCs exert their suppressive function on Tfh cells partially through the miR-142-5p/RC3H1 axis. Notably, IL-10-ADSCs subconjunctivally administered after disease onset efficiently ameliorated the severity of autoimmune dacryoadenitis. CONCLUSIONS: IL-10-ADSCs ameliorate autoimmune dacryoadenitis by suppressing Tfh cell responses via suppressing the miR-142-5p/RC3H1 axis. The enhanced therapeutic effects of IL-10-ADSCs could be of significant value in improving the effectiveness of stem cell therapy in autoimmune dry eye.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhao L, Li N, Shi X, et al. Enhanced Therapeutic Effect of IL-10-ADSCs on Rabbit Autoimmune Dacryoadenitis By Suppressing T Follicular Helper Cell Responses Via miR-142-5p/RC3H1 Axis. Invest Ophthalmol Vis Sci. 2025. PMID: 40261659. doi:10.1167/iovs.66.4.66

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。